In separate models, we did observe a modest accounting of variance by cerebrovascular disease risk on entorhinal cortex tau burden after accounting for the association of global amyloid burden, consistent with prior reports33,58 that cerebrovascular disease and amyloid pathology can concurrently influence tau burden. The gene discussed is MAPT; the disease is cerebrovascular disorder.